Company: GNMSF
Filing Date: 2025-07-03
Form Type: F-6
Source: 0001104659-25-065682
Chunk: 3

Company: GENMAB A/S
Filing Date: 2025-07-03
Form: F-6
Chunk 3
---
 three years. Not Applicable.     |

| (d) | Opinion of Norton Rose Fulbright US LLP, counsel to the Depositary, as to the legality of the securities 
 being registered. Filed herewith as Exhibit (d).                                                         |

| (e) | Certification under Rule 466. Not Applicable. |

| (f) | Power of Attorney of certain officers and directors of the Company. Set forth on the signature 
 pages hereto.                                                                                  |

Item 4. UNDERTAKINGS

| (a) | The Depositary hereby undertakes to make available at the principal office of the Depositary in the United                            
 States, for inspection by holders of the American Depositary Receipts, any reports and communications received from the issuer of the 
 deposited securities which are both (1) received by the Depositary as the holder of the deposited securities, and (2) made generally  
 available to the holders of the underlying securities by the issuer.                                                                  |

| (b) | If the amounts of fees charged are not disclosed in the prospectus, the Depositary undertakes to prepare                                   
 a separate document stating the amount of any fee charged and describing the service for which it is charged and to deliver promptly a     
 copy of such fee schedule without charge to anyone upon request. The Depositary undertakes to notify each registered holder of an American 
 Depositary Receipt thirty days before any change in the fee schedule.                                                                      |

<div align='center'>SIGNATURES</div>

Pursuant to the
requirements of the Securities Act of 1933, as amended, JPMorgan Chase Bank, N.A., acting solely in its capacity as depositary (the “Depositary”)
on behalf of the legal entity created by the Second Amended and Restated Deposit Agreement (the “Deposit Agreement”) among
Genmab A/S, the Depositary and all Holders and Beneficial Owners from time to time of American Depositary Receipts (“ADRs”)
issued thereunder, certifies that it has reasonable grounds to believe that all the requirements for filing on Form F-6 are met and
has duly caused this Registration Statement on Form F-6 to be signed on its behalf by the undersigned, thereunto duly authorized,
in The City of New York, State of New York, on July 3, 2025.

| Legal entity created by the Deposit                                      
 Agreement for the issuance of ADRs evidencing American Depositary Shares |                                                                 |                        |
| By:                                                                      |